Inventiva (IVEVF) Non-Current Assets (2018 - 2025)
Inventiva (IVEVF) posted Non-Current Assets of $5.9 million for Q4 2025, down 65.6% on a QoQ basis from $17.1 million in Q2 2025, and down 26.34% year-over-year from $8.0 million in Q4 2024.
Analysis
Inventiva (IVEVF) Non-Current Assets (2018 - 2025) Analysis & Trends
Inventiva has reported Non-Current Assets for 8 years, with the latest figure at $5.9 million in Q4 2025.
- On a quarterly basis, Non-Current Assets fell 26.34% year-over-year to $5.9 million in Q4 2025; TTM through Dec 2025 was $5.9 million, a 26.34% decrease from a year earlier, with the FY2025 full-year figure at $5.9 million, down 26.34% from the prior year.
- Non-Current Assets was $5.9 million for Q4 2025 at Inventiva, down from $17.1 million in the prior quarter.
- The five-year high for Non-Current Assets was $23.0 million in Q4 2023, with the low at $5.9 million in Q4 2025.
- Average Non-Current Assets over 5 years is $12.3 million, with a median of $9.0 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Non-Current Assets soared 134.25% in 2023, then sank 65.35% in 2024.
- Over 5 years, Non-Current Assets stood at $7.3 million in 2021, then soared by 33.9% to $9.8 million in 2022, then jumped by 134.25% to $23.0 million in 2023, then tumbled by 65.35% to $8.0 million in 2024, then fell by 26.34% to $5.9 million in 2025.
- The last three Non-Current Assets figures came in at $5.9 million (Q4 2025), $17.1 million (Q2 2025), and $8.0 million (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.04 Bn | 624.28 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 440.25 Bn | 433.68 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 365.65 Bn | 358.51 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 266.64 Bn | 258.95 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn | 159.77 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 44.19 Bn | 44.19 Bn | - | 294.93 Mn |
| 8 | Incyte | 25.29 Bn | 20.75 Bn | 1.57 Bn | 1.85 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn | 3.74 Bn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | 5.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 5.87 Mn |
| Jun 30, 2025 | 17.06 Mn |
| Dec 31, 2024 | 7.97 Mn |
| Jun 30, 2024 | 18.54 Mn |
| Dec 31, 2023 | 22.99 Mn |
| Jun 30, 2023 | 20.09 Mn |
| Dec 31, 2022 | 9.82 Mn |
| Jun 30, 2022 | 9.03 Mn |
| Dec 31, 2021 | 7.33 Mn |
| Jun 30, 2021 | 8.89 Mn |
| Mar 31, 2021 | 8.21 Mn |
| Dec 31, 2020 | 7.06 Mn |
| Jun 30, 2020 | 9.42 Mn |
| Dec 31, 2019 | 8.95 Mn |
| Dec 31, 2018 | 9.33 Mn |